spironolactone has been researched along with sc70303 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cook, CS; Fischer, JS; Zhang, L | 1 |
Cook, CS; Zhang, L | 2 |
Ames, GB; Cook, CS; Fischer, J; Levin, S; Zhang, J; Zhang, L | 1 |
Chiba, K; Mori, Y; Ogata, H; Takahashi, H | 1 |
1 trial(s) available for spironolactone and sc70303
Article | Year |
---|---|
A population approach to eplerenone pharmacokinetics and saturable protein binding.
Topics: Area Under Curve; Asian People; Clinical Trials, Phase I as Topic; Eplerenone; Humans; Mineralocorticoid Receptor Antagonists; Models, Biological; Protein Binding; Spironolactone; White People | 2010 |
4 other study(ies) available for spironolactone and sc70303
Article | Year |
---|---|
Absorption and disposition of a selective aldosterone receptor antagonist, eplerenone, in the dog.
Topics: Administration, Oral; Administration, Rectal; Animals; Body Fluid Compartments; Dogs; Eplerenone; Feces; Female; Gastric Mucosa; Injections, Intravenous; Intestinal Absorption; Intestinal Mucosa; Male; Mineralocorticoid Receptor Antagonists; Mouth Mucosa; Spironolactone; Stomach | 2000 |
Atypical dose-route-dependent food effects of eplerenone in the dog: presence of food effects following intravenous dosing and lack of food effects of following oral dosing.
Topics: Administration, Oral; Animals; Area Under Curve; Dogs; Eplerenone; Food-Drug Interactions; Infusions, Intravenous; Liver; Mass Spectrometry; Mineralocorticoid Receptor Antagonists; Portal Vein; Spironolactone | 2002 |
Interconversion pharmacokinetics of eplerenone, a selective aldosterone blocker, and its lactone-ring open form.
Topics: Aldosterone; Animals; Dogs; Eplerenone; Female; Injections, Intravenous; Lactones; Models, Animal; Spironolactone | 2002 |
Single- and repeated-dose pharmacokinetics of eplerenone, a selective aldosterone receptor blocker, in rats.
Topics: Administration, Oral; Animals; Biotransformation; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Eplerenone; Feces; Female; Half-Life; In Vitro Techniques; Injections, Intravenous; Male; Microsomes, Liver; Mineralocorticoid Receptor Antagonists; Mixed Function Oxygenases; Rats; Rats, Sprague-Dawley; Sex Factors; Spironolactone; Subcellular Fractions | 2003 |